Astellas Pharma and YASKAWA Establish JV for Cell Therapy Product Manufacturing Platform
Japan-based Astellas Pharma Inc. (TYO: 4503) is set to establish a joint venture (JV) with...
Deals
Roche and JD Healthcare Collaborate on Influenza Prevention with Xofluza (Baloxavir Marboxil)
Swiss giant Roche’s (SWX: ROG, OTCMKTS: RHHBY) China unit has entered into a collaboration agreement...
Jiangsu Nhwa Pharmaceutical Invests in NeuroThree to Develop CNS Therapies
China-based Jiangsu Nhwa Pharmaceutical Co., Ltd (SHE: 002262) announced plans to subscribe to Hong Kong-headquartered...
Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) announced a commercialization agreement with Bayer (ETR: BAYN),...
Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has formed a partnership with compatriot firm...
Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs
China-based Lexenpharm has formed a partnership with compatriot firm Beijing Sun-Novo Pharmaceutical Research Co., Ltd...
Baheal Pharmaceutical Gains Exclusive Rights to Roche’s MabThera in China
China-based health services and distribution giant Baheal Pharmaceutical Group (SHE: 301015) last month reached an...
CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America
China-based CStone Pharmaceuticals (HKG: 2616) and Costa Rica-based drug maker and distributor SteinCares have entered...
Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
China-based Bio-Thera Solutions (SHA: 688177) has entered into a licensing agreement with World Medicine, granting...
Hainan Poly Pharm’s US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) announced a significant partnership between its US...
Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies
US-based AI-powered biotech Gensaic, Inc. announced the signing of a licensing and discovery cooperation agreement...
Boston Scientific to Acquire SoniVie, Boosting Hypertension Treatment Portfolio
Boston Scientific Corporation (NYSE: BSX) is set to acquire SoniVie Ltd, an Israel-based medical device...
Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development
Japan-based Kyorin Pharmaceutical Co., Ltd. announced a licensing agreement with Novartis (NYSE: NVS), granting the...
Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital
China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a...
Bayer HealthCare and JD Healthcare Partner on Women’s Health Ecosystem
German pharmaceutical giant Bayer HealthCare (ETR: BAYN) has entered into a new partnership with JD...
Geneseeq and MGI Tech Form Global Partnership for Oncology Solutions
Geneseeq Technology Inc., a genetic cancer testing service provider operating in Canada and China, has...
AbbVie Enters Obesity Field with Gubra’s GUB014295 Licensing Deal
US pharmaceutical giant AbbVie (NYSE: ABBV) announced that it is making significant progress in the...
Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone
A joint effort between Japan-based Omron Healthcare and China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), a...
WORK Medical and Chartwell Med Partner on Investment Tools for Healthcare Projects
WORK Medical Technology Group Ltd (NASDAQ: WOK), a medical consumables company based in Hangzhou, has...
Eyebright Medtech Plans Private Placement to Expand Contact Lens Production
China-based Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050), an ophthalmic medical device manufacturer, announced...